Paper36929425
BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
Shan F and 3 others. Int J Oncol, 2023. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway. Papers, record 36929425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36929425
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Squamous Cell | Major topic |
| Mouth Neoplasms | Major topic |
| Head and Neck Neoplasms | Major topic |
| Humans | |
| Squamous Cell Carcinoma of Head and Neck | |
| Proto-Oncogene Proteins c-akt | |
| MAP Kinase Signaling System | |
| Cell Proliferation | |
| Cell Line, Tumor | |
| Signal Transduction | |
| RNA, Small Interfering | |
| Transcription Factors | |
| Cell Movement | |
| Gene Expression Regulation, Neoplastic | |
| Antigens, CD | |
| Bone Marrow Stromal Antigen 2 | |
| STAT1 Transcription Factor |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36536301 | Tumor cells-derived conditioned medium induced pro-tumoral phenotypes in macrophages through calcium-nuclear factor κB interaction. | BMC Cancer | 2022 | https://conductscience.org/library/papers/36536301 | PubMed |
| 2 | 20193018 | Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells. | Immunol Rev | 2010 | https://conductscience.org/library/papers/20193018 | PubMed |
| 3 | 36731706 | Dissolvable sodium alginate-based antibacterial wound dressing patches: Design, characterization, and in vitro biological studies. | Int J Biol Macromol | 2023 | https://conductscience.org/library/papers/36731706 | PubMed |
| 4 | 31893516 | Head and Neck Cancer. | N Engl J Med | 2020 | https://conductscience.org/library/papers/31893516 | PubMed |
| 5 | 36176904 | I n situ synthesis and unidirectional insertion of membrane proteins in liposome-immobilized silica stationary phase for rapid preparation of microaffinity chromatography. | Acta Pharm Sin B | 2022 | https://conductscience.org/library/papers/36176904 | PubMed |
| 6 | 36456734 | Fungal sensing by dectin-1 directs the non-pathogenic polarization of TH17 cells through balanced type I IFN responses in human DCs. | Nat Immunol | 2022 | https://conductscience.org/library/papers/36456734 | PubMed |
| 7 | 35462576 | NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35462576 | PubMed |
| 8 | 33711249 | The viral restriction factor tetherin/BST2 tethers cytokinetic midbody remnants to the cell surface. | Curr Biol | 2021 | https://conductscience.org/library/papers/33711249 | PubMed |
| 9 | 36134201 | Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature. | Int J Nanomedicine | 2022 | https://conductscience.org/library/papers/36134201 | PubMed |
| 10 | 7708771 | Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7708771 | PubMed |
| 11 | 35995341 | STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/35995341 | PubMed |
| 12 | 31199522 | Severe acute respiratory syndrome coronavirus spike protein counteracts BST2-mediated restriction of virus-like particle release. | J Med Virol | 2019 | https://conductscience.org/library/papers/31199522 | PubMed |
| 13 | 36104359 | A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma. | Nat Commun | 2022 | https://conductscience.org/library/papers/36104359 | PubMed |
| 14 | 36077775 | Nodal Disease and Survival in Oral Cancer: Is Occult Metastasis a Burden Factor Compared to Preoperatively Nodal Positive Neck? | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36077775 | PubMed |
| 15 | 36820829 | RELA tunes innate-like interferon I/III responses in human T cells. | J Exp Med | 2023 | https://conductscience.org/library/papers/36820829 | PubMed |
| 16 | 29921905 | IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. | Nat Rev Immunol | 2018 | https://conductscience.org/library/papers/29921905 | PubMed |
| 17 | 33203701 | circIGHG-Induced Epithelial-to-Mesenchymal Transition Promotes Oral Squamous Cell Carcinoma Progression via miR-142-5p/IGF2BP3 Signaling. | Cancer Res | 2021 | https://conductscience.org/library/papers/33203701 | PubMed |
| 18 | 30082830 | Epigenetic control of innate and adaptive immune memory. | Nat Immunol | 2018 | https://conductscience.org/library/papers/30082830 | PubMed |
| 19 | 35316682 | Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy. | EBioMedicine | 2022 | https://conductscience.org/library/papers/35316682 | PubMed |
| 20 | 34908514 | STAT1 mediated long non-coding RNA LINC00504 influences radio-sensitivity of breast cancer via binding to TAF15 and stabilizing CPEB2 expression. | Cancer Biol Ther | 2021 | https://conductscience.org/library/papers/34908514 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42579075 | Identification of potential biomarkers for oral squamous cell carcinoma through multi-cohort bioinformatic analysis. | J Egypt Natl Canc Inst | 2026 | https://conductscience.org/library/papers/42579075 | PubMed |
| 42021133 | LUCAT1 drives arecoline-induced head and neck cancer progression via STAT1-mediated transcriptional regulation. | Cell Mol Biol Lett | 2026 | https://conductscience.org/library/papers/42021133 | PubMed |
| 41763536 | Bone Marrow Stromal Cell Antigen 2 Promotes Esophageal Squamous Cell Carcinoma Progression by Mediating the Cell-Cell Interaction between Cancer Cells and Cancer-Associated Fibroblasts. | Am J Pathol | 2026 | https://conductscience.org/library/papers/41763536 | PubMed |
| 41751238 | cGAS-STING Pathway-Induced BST2 Enhances HPV-Infected Keratinocyte Proliferation in Condyloma Acuminata. | Biomedicines | 2026 | https://conductscience.org/library/papers/41751238 | PubMed |
| 41281378 | BST2 Drives Epithelial Ovarian Cancer Progression via Macrophage M2 Polarization, Neural Remodeling, and Immunosuppressive Microenvironment Formation. | Hum Mutat | 2025 | https://conductscience.org/library/papers/41281378 | PubMed |
| 41255601 | Identification of anoikis-related genes and immune infiltration characteristics in Sjögren's syndrome based on machine learning. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41255601 | PubMed |
| 40691615 | CD317 stabilizes TNFR1 and confers the anti-inflammatory functions of MSCs via NF-κB/TSG6 pathway. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40691615 | PubMed |
| 40649981 | BST2 and DIRAS3 Drive Immune Evasion and Tumor Progression in High-Grade Glioma. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40649981 | PubMed |
| 40514669 | DNA hypomethylation modification promotes BST2 expression in cervical cancer by facilitating STAT1 binding to the promoter of BST2. | Infect Agent Cancer | 2025 | https://conductscience.org/library/papers/40514669 | PubMed |
| 40475773 | Machine learning-driven identification of exosome- related biomarkers in head and neck squamous cell carcinoma. | Front Immunol | 2025 | https://conductscience.org/library/papers/40475773 | PubMed |
| 40271514 | A comprehensive transcriptome based meta-analysis to unveil the aggression nexus of oral squamous cell carcinoma. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/40271514 | PubMed |
| 39650066 | Identification of key genes associated with endometriosis and endometrial cancer by bioinformatics analysis. | Front Oncol | 2024 | https://conductscience.org/library/papers/39650066 | PubMed |
| 38919957 | Uncovering periodontitis-associated markers through the aggregation of transcriptomics information from diverse sources. | Front Genet | 2024 | https://conductscience.org/library/papers/38919957 | PubMed |
| 38259290 | Network pharmacology and experiment validation investigate the potential mechanism of triptolide in oral squamous cell carcinoma. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38259290 | PubMed |
| 37373022 | The Role of IL-17 in the Pathogenesis of Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37373022 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| BST2 | 684 | PubTator's text mining | https://conductscience.org/library/genes/684 | NCBI Gene |
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| MAPK3 | 5595 | PubTator's text mining | https://conductscience.org/library/genes/5595 | NCBI Gene |
| MMUT | 4594 | PubTator's text mining | https://conductscience.org/library/genes/4594 | NCBI Gene |
| POTEF | 728378 | PubTator's text mining | https://conductscience.org/library/genes/728378 | NCBI Gene |
| STAT1 | 6772 | PubTator's text mining | https://conductscience.org/library/genes/6772 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36929425
GET https://conductscience.org/api/papers/v1/36929425/references?page=2